We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-20.84%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$37.7B
AUM Growth
-$10.7B
Cap. Flow
+$89.7M
Cap. Flow %
0.24%
Top 10 Hldgs %
24%
Holding
1,459
New
89
Increased
670
Reduced
570
Closed
85

Top Buys

Rank Stock Value
1
KGC icon
Kinross Gold
KGC
+$295M
2
SCHW
Charles Schwab
SCHW
+$97.8M
3
ROK icon
Rockwell Automation
ROK
+$97.4M
4
TRU icon
TransUnion
TRU
+$95.8M
5
ADBE icon
Adobe
ADBE
+$93.2M

Sector Composition

Rank Sector Weight
1 Materials 34.08%
2 Technology 25.82%
3 Energy 9.46%
4 Healthcare 7.07%
5 Financials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVCR icon
801
NovoCure
NVCR
$1.79B
$937K ﹤0.01%
13,486
-4,661
-26% -$351K
DK icon
802
Delek US
DK
$4.16B
$923K ﹤0.01%
+35,736
New +$964K
XBTF
803
DELISTED
VanEck Bitcoin Strategy ETF
XBTF
$916K ﹤0.01%
50,141
-86
-0.2% -$2.72K
MTUS icon
804
Metallus
MTUS
$826M
$912K ﹤0.01%
48,721
-8,547
-15% -$181K
HPQ icon
805
HP
HPQ
$24.5B
$910K ﹤0.01%
27,769
+254
+0.9% +$9.32K
DMB
806
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$194M
$907K ﹤0.01%
69,686
-27,861
-29% -$334K
MVT
807
DELISTED
BlackRock MuniVest Fund II
MVT
$900K ﹤0.01%
79,222
-14,084
-15% -$169K
BKH icon
808
Black Hills Corp
BKH
$5.47B
$899K ﹤0.01%
12,360
+84
+0.7% +$6.31K
HZNP
809
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$899K ﹤0.01%
11,268
-1,252
-10% -$119K
BKKT icon
810
Bakkt Inc
BKKT
$319M
$898K ﹤0.01%
17,111
+5,087
+42% +$428K
AM icon
811
Antero Midstream
AM
$10.2B
$897K ﹤0.01%
99,139
+9,618
+11% +$100K
BIO icon
812
Bio-Rad Laboratories Class A
BIO
$8.68B
$897K ﹤0.01%
1,813
-201
-10% -$105K
SSL icon
813
Sasol
SSL
$7.42B
$888K ﹤0.01%
38,513
-2,606
-6% -$64.1K
MQT
814
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$884K ﹤0.01%
77,095
-43,511
-36% -$498K
SU icon
815
Suncor Energy
SU
$79.2B
$884K ﹤0.01%
25,215
+8,595
+52% +$313K
RVTY icon
816
Revvity
RVTY
$12.7B
$877K ﹤0.01%
6,167
-12,676
-67% -$1.9M
AFRM icon
817
Affirm
AFRM
$24.5B
$876K ﹤0.01%
48,516
-8,433
-15% -$229K
VTNR
818
DELISTED
Vertex Energy, Inc
VTNR
$869K ﹤0.01%
82,590
-93,227
-53% -$1.1M
RYZ
819
Ryerson Holding Corp
RYZ
$1.39B
$860K ﹤0.01%
40,405
-7,066
-15% -$221K
WIX icon
820
WIX.com
WIX
$2.2B
$856K ﹤0.01%
13,064
-2,459
-16% -$180K
HE icon
821
Hawaiian Electric Industries
HE
$2.26B
$851K ﹤0.01%
20,804
+456
+2% +$19.2K
FLNC icon
822
Fluence Energy
FLNC
$1.84B
$850K ﹤0.01%
89,710
-5,790
-6% -$56.4K
ARCH
823
DELISTED
Arch Resources, Inc.
ARCH
$836K ﹤0.01%
5,844
+566
+11% +$90K
ZM icon
824
Zoom
ZM
$27.6B
$835K ﹤0.01%
7,734
-388
-5% -$40.9K
BTU icon
825
Peabody Energy
BTU
$2.63B
$832K ﹤0.01%
38,986
+1,606
+4% +$39.4K

Similar funds

VanEck Associates's Q2 2022 Portfolio in Review

As of Q2 2022, VanEck Associates held 1,459 positions worth $37.7B, down 22% from $48.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

VanEck Associates's Q2 2022 filing shows 89 new, 670 increased, 570 reduced and 85 closed positions. Its largest new stake was Blackstone Secured Lending: 1,057,237 shares worth $25M. The largest sale was SLB Ltd, an estimated $158M.

By sector, the portfolio is most concentrated in Materials at 34% of assets, down from 37% a quarter earlier, followed by Technology and Energy.

  • VanEck Associates's largest Q2 2022 buy was Blackstone Secured Lending: 1,057,237 shares worth $25M.
  • VanEck Associates added most to Kinross Gold in Q2 2022, an estimated $295M increase.
  • VanEck Associates's biggest Q2 2022 reduction was SLB Ltd, cutting an estimated $158M.
  • VanEck Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $117M.
  • VanEck Associates's ten largest holdings make up 24% of its $37.7B portfolio in Q2 2022.
  • VanEck Associates opened 89 new positions and closed 85 in Q2 2022.
  • VanEck Associates's portfolio value fell 22% quarter-over-quarter to $37.7B.

Based on VanEck Associates's 13F filing for Q2 2022, filed 3 Aug 2022.